Triumvira Immunologics, Inc.

9433 Bee Cave Rd
United States

NextGen Class of 2021
Show jobs for this employer

About Triumvira Immunologics, Inc.

Triumvira is developing unique, targeted autologous and allogeneic T cell therapeutics that co-opt the natural biology of T cells to treat a broad range of patients with cancer.

Our company is backed by a strong intellectual property portfolio and a management team with deep experience in cell therapy, oncology drug development and manufacturing. By accessing the latest industry technologies, we are pursuing highly innovative autologous and allogeneic approaches for our TAC-based programs. We have set out to help millions of patients defeat difficult-to-treat tumors through a potentially curative technology that naturally activates and regulates T cells.

If you want to work at the leading edge of cancer research, join us. We are looking for new talent with an eagerness to cure some of the most aggressive and life-threatening diseases. Ideal candidates have an equal amount of passion for making a difference in a patient’s life and ambition for becoming highly knowledgeable, established leaders.

20 articles with Triumvira Immunologics, Inc.